
Merrimack Pharmaceuticals MACK
Quarterly report 2024-Q1
added 05-15-2024
Merrimack Pharmaceuticals EBITDA per Share 2011-2026 | MACK
Annual EBITDA per Share Merrimack Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.14 | -0.13 | -0.18 | -0.385 | -1.88 | -4.61 | -6.84 | -7.82 | -11.3 | -6.04 | -11.9 | -12.2 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.13 | -12.2 | -5.29 |
Quarterly EBITDA per Share Merrimack Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | -0.04 | -0.04 | -0.01 | - | -0.04 | -0.06 | -0.05 | - | -0.08 | -0.09 | 0.02 | - | 0.1 | -0.53 | -0.66 | - | -1.01 | -1.12 | -1.21 | - | -1.07 | -2.45 | -2 | - | -2.42 | -0.27 | -0.29 | - | -0.3 | -0.15 | -0.27 | - | -0.2 | -0.11 | -0.22 | - | -0.34 | -0.29 | -0.28 | - | -0.22 | -0.2 | -1.93 | - | -1.28 | -2.37 | -1.2 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.1 | -2.45 | -0.63 |
EBITDA per Share of other stocks in the Biotechnology industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
4.25 | $ 330.34 | 3.6 % | $ 43.3 B | ||
|
BioLineRx Ltd.
BLRX
|
-0.04 | $ 2.25 | 1.81 % | $ 908 M | ||
|
I-Mab
IMAB
|
0.08 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
-2.24 | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M | ||
|
Midatech Pharma plc
MTP
|
-0.09 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | ||
|
Acorda Therapeutics
ACOR
|
-188 | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
-6.85 | - | - | $ 86.2 M | ||
|
Advaxis
ADXS
|
-5.96 | - | -9.65 % | $ 45.9 M | ||
|
Anavex Life Sciences Corp.
AVXL
|
-0.6 | $ 2.96 | -1.0 % | $ 252 M | ||
|
Applied Molecular Transport
AMTI
|
-3.2 | - | - | $ 10.1 M | ||
|
BioNTech SE
BNTX
|
62.6 | $ 91.28 | 0.11 % | $ 27.2 B | ||
|
Aeterna Zentaris
AEZS
|
-0.08 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-2.35 | - | -10.17 % | $ 12.2 K | ||
|
AIkido Pharma
AIKI
|
-3.89 | - | 1.93 % | $ 17.4 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.36 | - | - | $ 26.5 M | ||
|
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
-2.45 | - | 0.23 % | $ 488 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - | ||
|
Allena Pharmaceuticals
ALNA
|
-0.696 | - | 3.16 % | $ 1.9 M | ||
|
Alpine Immune Sciences
ALPN
|
-1.72 | - | - | $ 2.17 B | ||
|
Aileron Therapeutics
ALRN
|
-1.99 | - | 10.36 % | $ 9.8 M | ||
|
Aquestive Therapeutics
AQST
|
-0.66 | $ 4.09 | -0.97 % | $ 437 M | ||
|
Aravive
ARAV
|
-1.92 | - | -13.39 % | $ 1.45 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
-2.67 | $ 8.22 | 2.37 % | $ 225 M | ||
|
Aptose Biosciences
APTO
|
0.01 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-0.92 | - | -39.0 % | $ 4.57 M | ||
|
CureVac N.V.
CVAC
|
-2.22 | - | - | $ 867 M | ||
|
AstraZeneca PLC
AZN
|
0.74 | - | - | $ 96.9 B | ||
|
Celldex Therapeutics
CLDX
|
-4.28 | $ 31.37 | 1.0 % | $ 2.08 B | ||
|
Avenue Therapeutics
ATXI
|
-0.98 | - | -52.27 % | $ 4.45 M | ||
|
AVROBIO
AVRO
|
0.24 | - | 1083.1 % | $ 745 M | ||
|
Axcella Health
AXLA
|
-1.41 | - | -16.42 % | $ 249 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-0.09 | $ 23.66 | 0.11 % | $ 3.01 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.42 | - | - | $ 7.46 M | ||
|
BeiGene, Ltd.
BGNE
|
0.42 | - | 0.49 % | $ 251 B | ||
|
bluebird bio
BLUE
|
-1.97 | - | - | $ 546 M | ||
|
Allakos
ALLK
|
-2.19 | - | - | $ 28.6 M | ||
|
Brickell Biotech
BBI
|
-1.17 | - | -5.38 % | $ 6.06 M | ||
|
Ardelyx
ARDX
|
-0.16 | $ 5.97 | 0.51 % | $ 1.44 B | ||
|
Atreca
BCEL
|
0.14 | - | -11.76 % | $ 5.79 M | ||
|
CASI Pharmaceuticals
CASI
|
-0.304 | - | - | $ 35.4 M | ||
|
Ampio Pharmaceuticals
AMPE
|
0.15 | - | -11.43 % | $ 502 K | ||
|
ChemoCentryx
CCXI
|
-1.82 K | - | - | $ 3.74 B | ||
|
AlloVir
ALVR
|
-3.02 | - | 4.14 % | $ 49.1 M | ||
|
argenx SE
ARGX
|
-6.83 | $ 748.25 | 0.25 % | $ 25 B |